{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:32:58Z","timestamp":1781818378757,"version":"3.54.5"},"reference-count":0,"publisher":"MDPI AG","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Pharm."],"published-print":{"date-parts":[[2016]]},"DOI":"10.3797\/scipharm.1507-14","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T13:59:29Z","timestamp":1462715969000},"page":"233-254","source":"Crossref","is-referenced-by-count":6,"title":["Search for Compounds with Hypoglycemic Activity in the Series of 1-(2-(1H-Tetrazol-5-yl)-R1-Phenyl)-3-R2-phenyl(ethyl)ureas and R1-Tetrazolo[1,5-c]quinazolin-5(6H)-ones"],"prefix":"10.3390","volume":"84","author":[{"given":"Oleksii M.","family":"Antypenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","container-title":["Scientia Pharmaceutica"],"original-title":[],"deposited":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T09:07:20Z","timestamp":1500368840000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mdpi.com\/2218-0532\/84\/2\/233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3797\/scipharm.1507-14","relation":{},"ISSN":["0036-8709","2218-0532"],"issn-type":[{"value":"0036-8709","type":"print"},{"value":"2218-0532","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}